Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit

Johnson & Johnson has announced a landmark deal to pay an estimated $5.5 billion to resolve tens of thousands of lawsuits. These legal claims allege that the company's baby powder and other talc products caused ovarian cancer. The settlement covers approximately 76,000 claims, including those consolidated in a New Jersey federal court and various state court cases. This significant agreement aims to end a contentious, decade-long legal battle involving nearly all remaining talc claims against the company.